When Chemotherapy Leaves a Stamp: Bleomycin-Induced Flagellate Dermatitis - Clinical and Dermoscopic Features
EJC Skin Cancer · 2026 · 4 · 101080
DOI: 10.1016/j.ejcskn.2026.101080 ↗Kurz gefasst
Fachartikel in der Zeitschrift EJC Skin Cancer, 2026. Verfasst von A. Szlauer-Stefańska und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Szlauer-Stefańska, A., Twardosz, M., Kwiatkowska-Pamuła, A., Giebel, S., & Kamińska-Winciorek, G. (2026). When Chemotherapy Leaves a Stamp: Bleomycin-Induced Flagellate Dermatitis - Clinical and Dermoscopic Features. EJC Skin Cancer, 4, 101080. https://doi.org/10.1016/j.ejcskn.2026.101080
Vancouver
Szlauer-Stefańska A, Twardosz M, Kwiatkowska-Pamuła A, Giebel S, Kamińska-Winciorek G. When Chemotherapy Leaves a Stamp: Bleomycin-Induced Flagellate Dermatitis - Clinical and Dermoscopic Features. EJC Skin Cancer. 2026;4:101080. doi:10.1016/j.ejcskn.2026.101080
BibTeX
@article{SzlauerStefaska2026,
author = {Szlauer-Stefańska, A. and Twardosz, M. and Kwiatkowska-Pamuła, A. and Giebel, S. and Kamińska-Winciorek, G.},
title = {When Chemotherapy Leaves a Stamp: Bleomycin-Induced Flagellate Dermatitis - Clinical and Dermoscopic Features},
journal = {EJC Skin Cancer},
year = {2026},
volume = {4},
pages = {101080},
doi = {10.1016/j.ejcskn.2026.101080}
}
EUVIMED